Dyno Therapeutics: Funding, Investors & Team (Sep 2026)
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.
Dyno Therapeutics has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in May 2021.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Dyno Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2021.
Dyno Therapeutics Funding Rounds
Dyno Therapeutics Founders and Leadership Team
Contact details for the Dyno Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Dyno Therapeutics Funding Compared to Other Artificial Intelligence Startups
Dyno Therapeutics' latest round of $100M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dyno Therapeutics in Artificial Intelligence and Cambridge
Companies Similar to Dyno Therapeutics
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Dyno Therapeutics Funding FAQs
What does Dyno Therapeutics do?
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.
How much funding has Dyno Therapeutics raised?
Dyno Therapeutics has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in May 2021.
When did Dyno Therapeutics last raise funding?
Dyno Therapeutics' most recent funding round on record is an undisclosed round of $100M, announced in May 2021.
Who is the CEO of Dyno Therapeutics?
Eric Kelsic is listed as CEO at Dyno Therapeutics.
Where is Dyno Therapeutics headquartered?
Dyno Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Dyno Therapeutics have?
Dyno Therapeutics is in the 51-100 employee band.
How does Dyno Therapeutics' funding compare to other Artificial Intelligence startups?
Dyno Therapeutics' latest round of $100M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Dyno Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dyno Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.